Neoadjuvant and adjuvant chemotherapy in pancreatic cancer

被引:0
作者
Ulla Klaiber
Carl-Stephan Leonhardt
Oliver Strobel
Christine Tjaden
Thilo Hackert
John P. Neoptolemos
机构
[1] University of Heidelberg,Department of General, Visceral and Transplantation Surgery
来源
Langenbeck's Archives of Surgery | 2018年 / 403卷
关键词
Pancreatic cancer; Neoadjuvant chemotherapy; Adjuvant chemotherapy; Evidence-based medicine; Transcriptomics; Precision medicine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:917 / 932
页数:15
相关论文
共 1020 条
[1]  
Siegel RL(2018)Cancer statistics, 2018 CA Cancer J Clin 68 7-30
[2]  
Miller KD(2016)Pancreatic cancer Nat Dis Primers 2 16022-348
[3]  
Jemal A(2018)Therapeutic developments in pancreatic cancer: current and future perspectives Nat Rev Gastroenterol Hepatol 15 333-23
[4]  
Kleeff J(2012)Understanding metastasis in pancreatic cancer: a call for new clinical approaches Cell 148 21-1733
[5]  
Korc M(2009)Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement Ann Surg Oncol 16 1727-1046
[6]  
Apte M(2006)Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy Ann Surg Oncol 13 1035-846
[7]  
La Vecchia C(2008)Borderline resectable pancreatic cancer: the importance of this emerging stage of disease J Am Coll Surg 206 833-988
[8]  
Johnson CD(2014)Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) Surgery 155 977-10
[9]  
Biankin AV(2017)Can neoadjuvant therapy in pancreatic cancer increase the pool of patients eligible for pancreaticoduodenectomy? Adv Surg 51 1-11
[10]  
Neale RE(2018)International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017 Pancreatology 18 2-5756